OverviewChartNewsTraderScreen

DZ Bank Call 1.5 MDGD 19.12.2025/  DE000DQ28EH3  /

Frankfurt Zert./DZB
6/20/2024  9:35:10 PM Chg.+0.010 Bid9:55:07 PM Ask9:55:07 PM Underlying Strike price Expiration date Option type
0.250EUR +4.17% -
Bid Size: -		 -
Ask Size: -		 MEDIGENE AG NA O.N. 1.50 EUR 12/19/2025 Call
GlobeNewswire 6/20 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 6/11 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 5/28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 5/21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 5/15 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 5/14 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 5/7 Medigene to Present at Upcoming Conferences
GlobeNewswire 5/6 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 5/2 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 5/2 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 4/26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 4/25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 4/17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 4/8 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 4/4 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 3/28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 3/18 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 3/6 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 3/4 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 2/29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 2/19 Medigene to Present at Upcoming Conferences
GlobeNewswire 2/12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 12/19/2023 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 11/21/2023 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...